{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T13:26:26Z","timestamp":1774358786872,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1016\/j.jaad.2004.10.879","type":"journal-article","created":{"date-parts":[[2006,1,27]],"date-time":"2006-01-27T10:34:01Z","timestamp":1138358041000},"page":"242-250","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Adapalene gel 0.3% for the treatment of acne vulgaris: A multicenter, randomized, double-blind, controlled, phase III trial"],"prefix":"10.1016","volume":"54","author":[{"given":"Diane","family":"Thiboutot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Pariser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Egan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Flores","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"James H.","family":"Herndon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norman B.","family":"Kanof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven E.","family":"Kempers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart","family":"Maddin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yves P.","family":"Poulin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David C.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joyce","family":"Hwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Graeber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2004.10.879_bib1","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/1523-1747.ep12541101","article-title":"Prevalence, morbidity, and cost of dermatologic diseases","volume":"73","year":"1979","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2004.10.879_bib2","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1136\/bmj.1.6171.1109","article-title":"Prevalence of facial acne vulgaris in late adolescence and in adults","volume":"1","author":"Cunliffe","year":"1979","journal-title":"Br Med J"},{"key":"10.1016\/j.jaad.2004.10.879_bib3","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/21548331.1998.11443640","article-title":"Acne vulgaris: a treatment update","volume":"33","author":"Usatine","year":"1998","journal-title":"Hosp Pract (Off Ed)"},{"issue":"Suppl","key":"10.1016\/j.jaad.2004.10.879_bib4","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/0190-9622(95)90416-6","article-title":"New understandings of the pathogenesis of acne","volume":"32","author":"Leyden","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2004.10.879_bib5","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0278-2391(98)90467-0","article-title":"Current concepts in the pathogenesis and treatment of acne","volume":"56","author":"Baur","year":"1998","journal-title":"J Oral Maxillofac Surg"},{"issue":"Suppl","key":"10.1016\/j.jaad.2004.10.879_bib6","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1067\/mjd.2003.618","article-title":"Management of acne: a report from a global alliance to improve outcomes in acne","volume":"49","author":"Gollnick","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2004.10.879_bib7","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000017844","article-title":"Topical drug treatment in acne","volume":"196","author":"Gollnick","year":"1998","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2004.10.879_bib8","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2165\/00003495-199753030-00010","article-title":"Adapalene: a review of its pharmacological properties and clinical potential in the management of mild to moderate acne","volume":"53","author":"Brogden","year":"1997","journal-title":"Drugs"},{"issue":"Suppl","key":"10.1016\/j.jaad.2004.10.879_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1365-2133.1998.1390s2003.x","article-title":"Pharacology of adapalene","volume":"139","author":"Michel","year":"1998","journal-title":"Br J Dermatol"},{"issue":"Suppl","key":"10.1016\/j.jaad.2004.10.879_bib10","first-page":"123","article-title":"Regulation of human monocyte toll-like receptor 2 (TLR2) expression by adapalene","volume":"16","author":"Vega","year":"2002","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"Suppl","key":"10.1016\/j.jaad.2004.10.879_bib11","doi-asserted-by":"crossref","first-page":"S126","DOI":"10.1016\/S0190-9622(97)70056-2","article-title":"Clinical efficacy and safety comparison of adapalene gel and tretinoin gel in the treatment of acne vulgaris: Europe and US multicenter trials","volume":"36","author":"Cunliffe","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2004.10.879_bib12","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0190-9622(96)90443-0","article-title":"A comparison of the efficacy and safety of adapalene gel 0.1% and tretinoin gel 0.025% in the treatment of acne vulgaris: a multicenter trial","volume":"34","author":"Shalita","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2004.10.879_bib13","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1046\/j.1365-2133.1998.1390s2026.x","article-title":"Evaluation of clinical efficacy and safety of adapalene 0.1% gel versus tretinoin 0.025% gel in the treatment of acne vulgaris, with particular reference to the onset of action and impact on quality of life","volume":"139","author":"Grosshans","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2004.10.879_bib14","first-page":"10","article-title":"Randomized controlled trial of the tolerability, safety, and efficacy of adapalene gel 0.1% and tretinoin microsphere gel 0.1% for the treatment of acne vulgaris","volume":"68","author":"Thiboutot","year":"2001","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2004.10.879_bib15","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1046\/j.1365-2133.1998.1390s2048.x","article-title":"A comparison of the efficacy and tolerability of adapalene 0.1% gel versus tretinoin 0.025% gel in patients with acne vulgaris: a meta-analysis of five randomized trials","volume":"139","author":"Cunliffe","year":"1998","journal-title":"Br J Dermatol"},{"issue":"Suppl","key":"10.1016\/j.jaad.2004.10.879_bib16","doi-asserted-by":"crossref","first-page":"S211","DOI":"10.1067\/S0190-9622(03)01152-6","article-title":"Efficacy and tolerability of combined topical treatment of acne vulgaris with adapalene and clindamycin: a multicenter, randomized, investigator-blinded study","volume":"49","author":"Wolf","year":"2003","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl","key":"10.1016\/j.jaad.2004.10.879_bib17","doi-asserted-by":"crossref","first-page":"S218","DOI":"10.1067\/S0190-9622(03)01153-8","article-title":"Is combined oral and topical therapy better than oral therapy alone in patients with moderate to moderately severe acne vulgaris? A comparison of the efficacy and safety of lymecycline plus adapalene gel 0.1%, versus lymecycline plus gel vehicle","volume":"49","author":"Cunliffe","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2004.10.879_bib18","doi-asserted-by":"crossref","unstructured":"Dosik JS, Homer K, Arsonnaud S. Cumulative irritation potential of adapalene cream and gel, 0.1% compared to tazarotene cream, 0.05% and 0.1%. Cutis 2005;75:289-93.","DOI":"10.1016\/j.jaad.2003.10.255"},{"key":"10.1016\/j.jaad.2004.10.879_bib19","first-page":"76","article-title":"Cumulative irritation comparison of adapalene gel and solution with 2 tazarotene gels and 3 tretinoin formulations","volume":"72","author":"Greenspan","year":"2003","journal-title":"Cutis"},{"issue":"Suppl","key":"10.1016\/j.jaad.2004.10.879_bib20","doi-asserted-by":"crossref","first-page":"S227","DOI":"10.1067\/S0190-9622(03)01151-4","article-title":"Cumulative irritancy comparison of adapalene gel 0.1% versus other retinoid products when applied in combination with topical antimicrobial agents","volume":"49","author":"Brand","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2004.10.879_bib21","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1046\/j.1365-2133.1998.1390s2017.x","article-title":"Adapalene 0.1% gel for the treatment of acne vulgaris: its superiority compared to tretinoin 0.025% cream in skin tolerance and patient preference","volume":"139","author":"Dunlap","year":"1998","journal-title":"Br J Dermatol"},{"issue":"Suppl","key":"10.1016\/j.jaad.2004.10.879_bib22","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1016\/S0190-9622(97)70052-5","article-title":"Split-face comparison of adapalene 0.1% gel and tretinoin 0.025% gel in acne patients","volume":"36","author":"Caron","year":"1997","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl","key":"10.1016\/j.jaad.2004.10.879_bib23","first-page":"20","article-title":"Randomized, controlled, bilateral (split-face) comparison trial of the tolerability and patient preference of adapalene gel 0.1% and tretinoin microsphere gel 0.1% for the treatment of acne vulgaris","volume":"68","author":"Egan","year":"2001","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2004.10.879_bib24","first-page":"145","article-title":"The efficacy and safety of adapalene gel 0.3% in the treatment of acne vulgaris: A randomized, multicenter, investigator-blinded, controlled comparison study versus adapalene gel 0.1% and vehicle","volume":"76","author":"Pariser","year":"2005","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2004.10.879_bib25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/biomet\/73.1.13","article-title":"Longitudinal data analysis using generalized linear models","volume":"73","author":"Liang","year":"1986","journal-title":"Biometrika"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962204038368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962204038368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T21:39:55Z","timestamp":1759268395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962204038368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["S0190962204038368"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2004.10.879","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1086157.539142","asserted-by":"object"}]},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2006,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adapalene gel 0.3% for the treatment of acne vulgaris: A multicenter, randomized, double-blind, controlled, phase III trial","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2004.10.879","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}